RGDXQ (Response Genetics) Other Stockholders Equity: $-0.00 Mil (As of Dec. 2015)


What is Response Genetics Other Stockholders Equity?

Response Genetics RGDXQ -98.00% Other Stockholders Equity is $-0.00 Mil as of Dec. 2015.

Response Genetics's Other Stockholders Equity for the quarter that ended in Dec. 2015 was $-0.00 Mil.

Response Genetics's quarterly Other Stockholders Equity increased from Dec. 2014 ($0.00 Mil) to Mar. 2015 ($0.00 Mil) but then declined from Mar. 2015 ($0.00 Mil) to Dec. 2015 ($-0.00 Mil).

Response Genetics's annual Other Stockholders Equity increased from Dec. 2013 ($-0.00 Mil) to Dec. 2014 ($0.00 Mil) but then declined from Dec. 2014 ($0.00 Mil) to Dec. 2015 ($-0.00 Mil).

Response Genetics Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Response Genetics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Response Genetics Other Stockholders Equity Chart

Response Genetics Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.00 0.00 -0.00

Response Genetics Quarterly Data
Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Dec15
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.00

Response Genetics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
Response Genetics (RGDXQ) has a Other Stockholders Equity of $-0.00 Mil as of Dec. 2015. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Response Genetics and its competitors.
Is Response Genetics' Other Stockholders Equity too high?
Response Genetics' current Other Stockholders Equity is $-0.00 Mil.
How does Response Genetics' Other Stockholders Equity compare to PSID and GBSN?
Response Genetics' Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Response Genetics and its competitors. Response Genetics's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Response Genetics stock overvalued right now?
Response Genetics (RGDXQ) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Response Genetics (RGDXQ), the current Other Stockholders Equity is $-0.00 Mil as of Dec. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Response Genetics Business Description

Address 201 Route 17 North, 2nd Floor, Rutherford, NJ, USA, 07070
Response Genetics Inc develops and sells diagnostic tests. It provides molecular- and biomarker-based tests and services which enables physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. The group generates revenue from providing Biopharma Services, Clinical Services, and Discovery Services, of which majority of the revenue is derived from providing Biopharma Services. Biopharma services provide companies with customized solutions for patient stratification and treatment selection through molecular- and biomarker-based testing services, customized assay development and trial design consultation. The firm operates in the US and internationally and generates prime revenue from the US.